‘Watch China’ As Its Pharma Butterfly Flaps Its Wings
London Conference Told China’s Modernization Reforms Present ‘Paradigm Shift’
Executive Summary
More affordable drug prices worldwide could result from China’s ongoing reforms in the life sciences sector, the FT Global Pharmaceutical and Biotechnology Conference hears.